USANA Health Sciences (USNA) Earnings Date, Estimates & Call Transcripts $38.25 -1.77 (-4.42%) (As of 12/3/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends USANA Health Sciences Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 4EstimatedActual EPS (Oct. 22) $0.56 Beat By $0.07 Consensus EPS (Oct. 22) $0.49 USANA Health Sciences released Q3 2024 earnings on October 22, 2024, reporting an EPS of $0.56, which beat the consensus estimate of $0.49 by $0.07. Quarterly revenue was reported to be $200.22 million, below analysts' expectations of $208.45 million. With a trailing EPS of $2.83 and a P/E Ratio of 13.52, USANA Health Sciences' earnings are expected to grow 1.63% next year, from $2.45 to $2.49 per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckPowered by USNA Upcoming EarningsUSANA Health Sciences' next earnings date is estimated for Tuesday, February 4, 2025, based off prior year's reporting schedules. Get USANA Health Sciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on USANA Health Sciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataUSNA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.USNA Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Behind the MarketsEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that could devastate millions of Americans. These events have caused five major cracks in our economy... That's why I have moved 7-figures of my own money out of the stock market.Watch my emergency briefing here >>> USANA Health Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20242$0.63$0.75$0.69 Q2 20242$0.62$0.68$0.65 Q3 20242$0.46$0.51$0.49 Q4 20242$0.49$0.49$0.49 FY 20248$2.20$2.43$2.32 Q1 20251$0.73$0.73$0.73 Q2 20251$0.61$0.61$0.61 Q3 20251$0.64$0.64$0.64 Q4 20251$0.75$0.75$0.75 FY 20254$2.73$2.73$2.73 Q1 20261$0.82$0.82$0.82 Q2 20261$0.74$0.74$0.74 Q3 20261$0.77$0.77$0.77 USANA Health Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 2/4/2025(Estimated)-------10/22/2024Q3 2024$0.49$0.56+$0.07$0.56$208.45M$200.22M7/23/2024Q2 2024$0.65$0.54 -$0.11$0.54$218.64M$212.87M4/30/2024Q1 2024$0.69$0.86+$0.17$0.86$223.27M$227.80M2/6/2024Q4 2023$0.52$0.87+$0.35$0.87$206.70M$221.08M10/24/2023Q3 2023$0.64$0.59 -$0.05$0.59$212.24M$213.37M7/25/2023Q2 2023$0.70$0.89+$0.19$0.89$224.77M$238.20M Get the Latest News and Ratings for USNA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for USANA Health Sciences and its competitors with MarketBeat's FREE daily newsletter. 4/25/2023Q1 2023$0.77$0.95+$0.18$0.95-$248.36M2/7/2023Q4 2022$0.35$0.66+$0.31$0.66-$227.96M USANA Health Sciences Earnings - Frequently Asked Questions When is USANA Health Sciences's earnings date? USANA Health Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 4th, 2025 based off last year's report dates. Learn more on USNA's earnings history. What guidance has USANA Health Sciences issued on next quarter's earnings? USANA Health Sciences issued an update on its FY 2024 earnings guidance on Tuesday, October, 22nd. The company provided EPS guidance of 2.450-2.450 for the period, compared to the consensus EPS estimate of 2.500. The company issued revenue guidance of $850.0 million-$850.0 million, compared to the consensus revenue estimate of $861.9 million. Did USANA Health Sciences beat their earnings estimates last quarter? In the previous quarter, USANA Health Sciences (NYSE:USNA) reported $0.56 earnings per share (EPS) to beat the analysts' consensus estimate of $0.49 by $0.07. Learn more on analysts' earnings estimate vs. USNA's actual earnings. How can I listen to USANA Health Sciences's earnings conference call? The conference call for USANA Health Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read USANA Health Sciences's conference call transcript? The conference call transcript for USANA Health Sciences's latest earnings report can be read online. Read Transcript How much revenue does USANA Health Sciences generate each year? USANA Health Sciences (NYSE:USNA) has a recorded annual revenue of $921.01 million. How much profit does USANA Health Sciences generate each year? USANA Health Sciences (NYSE:USNA) has a recorded net income of $63.79 million. USNA has generated $2.83 earnings per share over the last four quarters. What is USANA Health Sciences's price-to-earnings ratio? USANA Health Sciences (NYSE:USNA) has a trailing price-to-earnings ratio of 13.52 and a forward price-to-earnings ratio of 15.61. The price/earnings-to-growth ratio is 1.36. What is USANA Health Sciences's EPS forecast for next year? USANA Health Sciences's earnings are expected to grow from $2.45 per share to $2.49 per share in the next year, which is a 1.63% increase. More Earnings Resources from MarketBeat Related Companies HLF Earnings Results NUS Earnings Results NATR Earnings Results MED Earnings Results VERU Earnings Results EL Earnings Results IPAR Earnings Results PBH Earnings Results TLRY Earnings Results CRON Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Even Trump can’t stop what’s coming. (Ad)No matter who sits in the White House over the next four years, a series of events has been triggered that could devastate millions of Americans. These events have caused five major cracks in our economy... That's why I have moved 7-figures of my own money out of the stock market.Watch my emergency briefing here >>> This page (NYSE:USNA) was last updated on 12/4/2024 by MarketBeat.com Staff From Our PartnersElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredLock in this share price before 12/5When the team that built Zillow into a $16B real estate leader launches a new company, it’s worth paying atten...Pacaso | SponsoredCoins Set to Soar with a Pro-Crypto White HouseCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredHas World War III already started?As global tensions are rising, so does the potential of direct conflict between the US and China. That's wh...Behind the Markets | SponsoredMeet the NYSE traded company behind a potentially blockbuster antiviral drugThis public company’s one lead drug alone, NV-387, potentially addresses a $2.5 to $4.3 billion market Imag...Smallcaps Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding USANA Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share USANA Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
